Bayer Pharmaceuticals Corporation Pharmaceutical Division, West Haven, CT; Including Employees of Bayer Pharmaceuticals Corporation, Pharmaceutical Division, West Haven, CT, Located in the Following States: TA-W-53,129QQ Delaware, TA-W-53,129RR Iowa, TA-W-53,129SS Maine, TA-W-53,129TT Nebraska, TA-W-53,129UU Vermont, TA-W-53,129VV District Of Columbia, 15644 [E5-1355]

Download as PDF 15644 Federal Register / Vol. 70, No. 58 / Monday, March 28, 2005 / Notices Form Number: OJP FORM 4587/1. Office of Justice Programs. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: State, local or tribal government. Other: Federal government, individuals or households, not-for-profit institutions. The Uniform Administrative Requirements for Grants and Cooperative Agreements—28 CFR part 66, and OMB Circular A–100— authorizes the Department of Justice to collect information from grantees to report on project activities and accomplishments. Grantees that are recipients of a discretionary grant, as well as some formula grants, are required by OJP to report project activities and accomplishments by submitting Categorical Assistance Progress Reports. These reports are expected to include details regarding the stage of project development and data regarding accomplishments to date. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond/reply: It is estimated that 10, 366 respondents will take approximately two hours to complete each semi-annual submission of the Categorical Assistance Progress Report for a total of four hours annually per grantee. (6) An estimate of the total public burden (in hours) associated with the collection: There are an estimated 44,164 total annual burden hours associated with this collection. If additional information is required contact: Brenda E. Dyer, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street, NW., Washington, DC 20530. Dated: March 22, 2005. Brenda E. Dyer, Department Clearance Officer, Department of Justice. [FR Doc. 05–6020 Filed 3–25–05; 8:45 am] BILLING CODE 4410–18–P VerDate jul<14>2003 15:12 Mar 25, 2005 Jkt 205001 The amended notice applicable to TA–W–53,129 is hereby issued as follows: DEPARTMENT OF LABOR Employment and Training Administration [TA–W–53,129] Bayer Pharmaceuticals Corporation Pharmaceutical Division, West Haven, CT; Including Employees of Bayer Pharmaceuticals Corporation, Pharmaceutical Division, West Haven, CT, Located in the Following States: TA–W–53,129QQ Delaware, TA–W– 53,129RR Iowa, TA–W–53,129SS Maine, TA–W–53,129TT Nebraska, TA– W–53,129UU Vermont, TA–W–53,129VV District Of Columbia Amended Notice of Certification Regarding Eligibility To Apply for Worker Adjustment Assistance In accordance with Section 223 of the Trade Act of 1974 (19 U.S.C. 2273) the Department of Labor issued a Notice of Certification Regarding Eligibility to Apply for Worker Adjustment Assistance on October 24, 2003, applicable to workers of Bayer Pharmaceuticals Corporation, Pharmaceutical Division, West Haven, Connecticut. The notice was published in the Federal Register on November 28, 2003 (68 FR 66878). The certification was amended on February 1, 2005 to include workers of the West Haven, Connecticut facility of the subject firm located in many states throughout the United States. The notice was published in the Federal Register on February 22, 2005 (70 FR 8636–8637). At the request of the State agency, the Department reviewed the certification for workers of the subject firm. New information shows that workers were separated involving employees of the West Haven, Connecticut facility of Bayer Pharmaceuticals Corporation, Pharmaceutical Division located in the above mentioned states. These employees provided sales support services for the production of pharmaceutical products at the West Haven, Connecticut location of the subject firm. Based on these findings, the Department is amending this certification to include employees of the West Haven, Connecticut facility of Bayer Pharmaceuticals Corporation, Pharmaceutical Division, located in the above mentioned states. The intent of the Department’s certification is to include all workers of Bayer Pharmaceuticals Corporation, Pharmaceutical Division, West Haven, Connecticut, who were adversely affected by increased imports. PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 ‘‘All workers of Bayer Pharmaceuticals Corporation, Pharmaceutical Division, West Haven, Connecticut (TA–W–53,129), including employees of Bayer Pharmaceuticals Corporation, Pharmaceutical Division, West Haven, Connecticut, located in the following states: Delaware (TA–W– 53,129QQ), Iowa (TA–W–53,129RR), Maine (TA–W–53,129SS), Nebraska (TA–W– 53,129TT), Vermont (TA–W–53,129UU) and District of Columbia (TA–W–53,129VV), who became totally or partially separated from employment on or after October 1, 2002, through October 24, 2005, are eligible to apply for adjustment assistance under Section 223 of the Trade Act of 1974.’’ Signed at Washington, DC this 14th day of March 2005. Richard Church, Certifying Officer, Division of Trade Adjustment Assistance. [FR Doc. E5–1355 Filed 3–25–05; 8:45 am] BILLING CODE 4510–30–P DEPARTMENT OF LABOR Employment and Training Administration Investigations Regarding Certifications of Eligibility To Apply for Worker Adjustment Assistance Petitions have been filed with the Secretary of Labor under Section 221(a) of the Trade Act of 1974 (‘‘the Act’’) and are identified in the Appendix to this notice. Upon receipt of these petitions, the Director of the Division of Trade Adjustment Assistance, Employment and Training Administration, has instituted investigations pursuant to Section 221(a) of the Act. The purpose of each of the investigations is to determine whether the workers are eligible to apply for adjustment assistance under Title II, Chapter 2, of the Act. The investigations will further relate, as appropriate, to the determination of the date on which total or partial separations began or threatened to begin and the subdivision of the firm involved. The petitioners or any other persons showing a substantial interest in the subject matter of the investigations may request a public hearing, provided such request is filed in writing with the Director, Division of Trade Adjustment Assistance, at the address shown below, not later than April 7, 2005. Interested persons are invited to submit written comments regarding the subject matter of the investigations to the Director, Division of Trade Adjustment Assistance, at the address E:\FR\FM\28MRN1.SGM 28MRN1

Agencies

[Federal Register Volume 70, Number 58 (Monday, March 28, 2005)]
[Notices]
[Page 15644]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E5-1355]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Employment and Training Administration

[TA-W-53,129]


Bayer Pharmaceuticals Corporation Pharmaceutical Division, West 
Haven, CT; Including Employees of Bayer Pharmaceuticals Corporation, 
Pharmaceutical Division, West Haven, CT, Located in the Following 
States: TA-W-53,129QQ Delaware, TA-W-53,129RR Iowa, TA-W-53,129SS 
Maine, TA-W-53,129TT Nebraska, TA-W-53,129UU Vermont, TA-W-53,129VV 
District Of Columbia

Amended Notice of Certification Regarding Eligibility To Apply for 
Worker Adjustment Assistance

    In accordance with Section 223 of the Trade Act of 1974 (19 U.S.C. 
2273) the Department of Labor issued a Notice of Certification 
Regarding Eligibility to Apply for Worker Adjustment Assistance on 
October 24, 2003, applicable to workers of Bayer Pharmaceuticals 
Corporation, Pharmaceutical Division, West Haven, Connecticut. The 
notice was published in the Federal Register on November 28, 2003 (68 
FR 66878). The certification was amended on February 1, 2005 to include 
workers of the West Haven, Connecticut facility of the subject firm 
located in many states throughout the United States. The notice was 
published in the Federal Register on February 22, 2005 (70 FR 8636-
8637).
    At the request of the State agency, the Department reviewed the 
certification for workers of the subject firm. New information shows 
that workers were separated involving employees of the West Haven, 
Connecticut facility of Bayer Pharmaceuticals Corporation, 
Pharmaceutical Division located in the above mentioned states. These 
employees provided sales support services for the production of 
pharmaceutical products at the West Haven, Connecticut location of the 
subject firm.
    Based on these findings, the Department is amending this 
certification to include employees of the West Haven, Connecticut 
facility of Bayer Pharmaceuticals Corporation, Pharmaceutical Division, 
located in the above mentioned states.
    The intent of the Department's certification is to include all 
workers of Bayer Pharmaceuticals Corporation, Pharmaceutical Division, 
West Haven, Connecticut, who were adversely affected by increased 
imports.
    The amended notice applicable to TA-W-53,129 is hereby issued as 
follows:

    ``All workers of Bayer Pharmaceuticals Corporation, 
Pharmaceutical Division, West Haven, Connecticut (TA-W-53,129), 
including employees of Bayer Pharmaceuticals Corporation, 
Pharmaceutical Division, West Haven, Connecticut, located in the 
following states: Delaware (TA-W-53,129QQ), Iowa (TA-W-53,129RR), 
Maine (TA-W-53,129SS), Nebraska (TA-W-53,129TT), Vermont (TA-W-
53,129UU) and District of Columbia (TA-W-53,129VV), who became 
totally or partially separated from employment on or after October 
1, 2002, through October 24, 2005, are eligible to apply for 
adjustment assistance under Section 223 of the Trade Act of 1974.''

    Signed at Washington, DC this 14th day of March 2005.
Richard Church,
Certifying Officer, Division of Trade Adjustment Assistance.
[FR Doc. E5-1355 Filed 3-25-05; 8:45 am]
BILLING CODE 4510-30-P